RecruitingNot ApplicableNCT07341087

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial (SIPPI)


Sponsor

King's College London

Enrollment

30 participants

Start Date

Apr 28, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will explore whether a daily probiotic drink containing Lactobacillus casei Shirota (LcS) can help improve immune function and reduce inflammation in women going through the menopausal transition. Hormonal changes during this stage of life can affect the immune system, gut health, and skin, sometimes leading to increased inflammation or conditions such as eczema, acne or rosacea. Participants will consume either a low-sugar LcS probiotic drink or a skimmed milk control drink every day for eight weeks. The study will assess markers of immune ageing, inflammation, skin health, wellbeing, and hormone levels. The results will help determine whether a safe, non-hormonal probiotic approach may support immune and skin health during the menopausal transition.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Lactobacillus casei Shirota (LcS) Probiotic Drink and Skimmed Milk Control Drink for people with acne, eczema, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTLactobacillus casei Shirota (LcS) Probiotic Drink

Daily intake of 130 ml low-sugar fermented milk drink containing Lactobacillus casei Shirota for 8 weeks.

OTHERSkimmed Milk Control Drink

Daily intake of 130 ml skimmed milk for 8 weeks.


Locations(1)

Metabolic Research Unit, 4th Floor (Corridor A), Franklin-Wilkins Building, KCL.

London, London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07341087


Related Trials